A look at how the new disposable nasopharyngolaryngoscope (NPL) compare in quality and cost to the reusable NPL.
Nasal Swell Body Reduction Can Relieve Obstruction in Septal Perforation Repair Patients
Nasal swell body (NSB) can be surgically reduced, without re-perforation, to relieve obstructive symptoms.
Significant Clinical and Self-Assessed Differences Exist Between Patients With and Without Flavor Loss
A look at why some patients with olfactory disorder (OD) report smell and flavor loss while others report smell loss only.
Olfactory Fluctuation Presence Is Significant Within a Clinical Context
Olfactory fluctuation is mostly associated with sinonasal disease and elevated Sniffin’ Sticks scores, and its presence is valuable information when used in clinical context in a patient workup.
Understanding Use of Image Guidance Technology in Endoscopic Sinus Surgery
A look at how use of image guidance in endoscopic sinus surgery is associated with surgical outcomes, complications, and surgeon factors.
Steroid Therapy Comparable to Surgery for Patients with CRS with Nasal Polyps
Preoperatively administered GCS improved olfaction in CRS patients with nasal polyps is comparable to surgery, and changes in steroids predicted olfactory outcome postoperatively.
What Are Common Balloon Sinuplasty Complications?
The most common complications associated with balloon sinuplasty (BSP) include balloon malfunction, cerebrospinal fluid leak and significant eye swelling.
Mucosal Flap Preservation May Not Be Required for Successful Outcomes with eDCR
Outcomes of powered eDCR without the preservation of mucosal flaps compare favorably to previously reported results.
Analyzing Effects of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression
Continuation of esketamine nasal spray in addition to oral antidepressant treatment resulted in clinically meaningful superiority in delaying relapse for patients with TRD.
Analysis of Five-Year Recurrence Patterns in Sinonasal Cancer
Sinonasal cancer shows an 11.7% recurrence rate after a five-year disease- free period, but varies by tumor pathology.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 16
- Next Page »